What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory bench? The answer is arriving faster than many realize.For years, the relationship between artificial intelligence (AI) startups and big pharma followed a familiar script: a splashy press […]
